+80.1%
GSK vs FIVN
+238.7%
-158.7%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FIVN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -1.4% | +1.3% | 0.0% |
| 7D | -1.3% | -6.7% | +5.4% | -1.0% |
| 30D | +2.7% | -16.4% | +19.2% | +3.4% |
| 3M | +2.7% | -18.4% | +21.1% | +3.4% |
| 6M | +3.3% | +24.4% | -21.1% | +1.7% |
| YTD | +6.5% | +34.3% | -27.9% | +4.0% |
| 1Y | +10.7% | +32.9% | -22.2% | +8.0% |
| 3Y | +64.4% | -62.9% | +127.3% | +69.9% |
| 5Y | +46.7% | -83.8% | +130.5% | +56.7% |
| 10Y | +109.4% | +79.7% | +29.7% | +87.5% |
| All | +80.1% | +238.7% | -158.7% | +57.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FIVN.
Daily Out/Under-Performance
Portfolio return minus FIVN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FIVN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FIVN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling